The Venture Capital Catch-22
from the what-to-do? dept
Venture capitalists are in a bit of a catch-22 situation these days. The word is out that they simply won't invest any more, so they're seeing fewer business plans. Some VCs wish they would see more plans - but others say that only the better plans are getting through (which I think is questionable). A lot of the people I've spoken to recently who are trying to raise money don't have particularly good plans, but they are somewhat delusional about the state of the market these days. I think many of the smarter companies are looking for ways to survive that don't necessarily require submitting to the whims of VCs. Anyway, it's also interesting to see that the VCs themselves are doing pretty damn well raising money for their funds. That money has to go somewhere eventually. Hopefully not into special chairs to have sex in (a business plan discussed in the first link above, showing how "non-tech" businesses are now approaching VCs).
Thank you for reading this Techdirt post. With so many things competing for everyone’s attention these days, we really appreciate you giving us your time. We work hard every day to put quality content out there for our community.
Techdirt is one of the few remaining truly independent media outlets. We do not have a giant corporation behind us, and we rely heavily on our community to support us, in an age when advertisers are increasingly uninterested in sponsoring small, independent sites — especially a site like ours that is unwilling to pull punches in its reporting and analysis.
While other websites have resorted to paywalls, registration requirements, and increasingly annoying/intrusive advertising, we have always kept Techdirt open and available to anyone. But in order to continue doing so, we need your support. We offer a variety of ways for our readers to support us, from direct donations to special subscriptions and cool merchandise — and every little bit helps. Thank you.
–The Techdirt Team
Reader Comments
Subscribe: RSS
View by: Time | Thread
biotech
[ link to this | view in thread ]